Drug Approval | November 19, 2021
Natco launches Tipanat tablets in India
It is used for the treatment of advanced colorectal and gastric cancer
It is used for the treatment of advanced colorectal and gastric cancer
Taluka level transplant centre will add convenience to patients from rural areas
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
The system is a compact new addition to the Roche Molecular portfolio, providing efficiency, simplicity and timely results to laboratories of all sizes.
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Subscribe To Our Newsletter & Stay Updated
